The sum total of lifesciences knowledge is increasing at an exponential rate. At the same time, global and domestic competition for customers and research funding is growing even more intense. Now more than ever, companies that specialize in the development and marketing of medical, pharmaceutical, agricultural and other biotechnology-related products need experienced, informed legal counsel that can help them identify, protect and take full advantage of their intellectual property portfolios.
Our Lifesciences legal team includes lawyers with advanced degrees in biotechnology, chemistry and pharmacology, as well as in chemical, biomedical and mechanical engineering. Bracewell's attorneys have extensive technical and patent experience in the full range of lifesciences disciplines, including biologics, cell biology, chemistry, combinatorial chemistry, developmental biology, diagnostics, drug delivery, genomics, immunology, mechanical and biomedical engineering, molecular biology, oncology, plant physiology and agronomy, pharmaceuticals, and protein drug design.
The majority of our attorneys have also spent years working in these fields for major public and private companies, research institutions and regulatory agencies. This experience, when combined with our attorneys' recognized strength in intellectual property law, allows us to provide legal services that are specifically tailored to our clients' needs. Our Lifesciences practice counsels Fortune 500 businesses, educational institutions, and for-profit and not-for profit research centers involved in biotechnology, diagnostics, medical devices, pharmaceuticals and other specializations, and startup companies.
We advise clients in all aspects of intellectual property law, including the enforcement of technology rights and the negotiation of technology-based agreements, including licensing, joint development, asset purchase, distribution, and joint marketing technology agreements. Our cross-disciplinary team counsels companies ranging from Fortune 500 to startups with regard to company formation, debt and equity financing, environmental and regulatory matters, mergers and acquisitions, and dispute resolution and litigation.